Lazari Capital Management, Inc. Mesoblast LTD Transaction History

Lazari Capital Management, Inc.

  • $234 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 27, 2024
BUY
$1.0 - $1.39 $1,400 - $1,945
1,400 Added 1.49%
95,434 $105 Million
Q3 2023

Nov 07, 2023
BUY
$1.22 - $4.83 $9,760 - $38,640
8,000 Added 9.3%
94,034 $116 Million
Q2 2023

Jul 20, 2023
BUY
$2.95 - $4.44 $253,800 - $381,990
86,034 New
86,034 $336 Million

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Lazari Capital Management, Inc. Portfolio

Follow Lazari Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazari Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lazari Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email